B acillus megaterium, the "big beast," is a Gram-positive bacterium with a size of 4 x 1.5 µm. During the last years, it became more and more popular in the field of biotechnology for its recombinant protein production capacity. For the purpose of intra-as well as extracellular protein synthesis several vectors were constructed and commercialized (MoBiTec GmbH, Germany). On the basis of two compatible vectors, a T7 RNA polymerase driven protein production system was established. Vectors for chromosomal integration enable the direct manipulation of the genome. The vitamin B 12 biosynthesis of B. megaterium served as a model for the systematic development of a production strain using these tools. For this purpose, the overexpression of chromosomal and plasmid encoded genes and operons, the synthesis of anti-sense RNA for gene silencing, the removal of inhibitory regulatory elements in combination with the utilization of strong promoters, directed protein design, and the recombinant production of B 12 binding proteins to overcome feedback inhibition were successfully employed. For further system biotechnology based optimization strategies the genome sequence will provide a closer look into genomic capacities of B. megaterium. DNA arrays are available. Proteome, fluxome and metabolome analyses are possible. All data can be integrated by using a novel bioinformatics platform. Finally, the size of the "big beast" B. megaterium invites for cell biology research projects. All these features provide a solid basis for challenging biotechnological approaches.
The "Big Beast"
In 1884 de Bary named the Gram-positive bacterium Bacillus megaterium the "big beast" due to its large size. 1 With a cell length of up to 4 µm and a diameter of 1.5 µm, B. megaterium belongs to one of the biggest known bacteria. Compared to the model organism for Gram-negative bacteria, Escherichia coli, it has an up to 100-times higher volume ( Fig. 1) . Due to the dimensions of the vegetative form and spores, B. megaterium is an ideal model system for morphological research. It is well suited for the investigation of cell-wall biosynthesis, cytoplasmic membrane formation and the sporulation process including spore structure and organization. 2 In the 1960s, prior to the development of Bacillus subtilis, B. megaterium was "the" model organism of choice for intensive studies on biochemistry, sporulation and bacteriophages of Gram-positive bacteria. [3] [4] [5] [6] In 1994, Patricia Vary published the review "Prime-time for Bacillus megaterium." 7 In a recent review from 2007, 13 years later, she repeated this sentence and added ". . . now it is becoming true." 8
First Steps: Bacillus megaterium and Biotechnology
Due to its application for the production of biotechnological relevant substances, B. megaterium is of general interest for this branch of industry. 9 Beside its growth on cheap substrates, the non-pathogenic B. megaterium, in contrast to E. coli, does not produce endotoxins associated with an outer membrane. 7 Further, it does not culture were achieved. For upscaling the intracellular production process, GFP was produced under glucose limited high cell density conditions in a 2 liter bioreactor. The induced GFP synthesis, which could be easily pursued via the green fluorescence ( Fig. 2) , led to 274 mg GFP per liter cell culture. Further, these experiments clearly showed that the xylose-inducible promoter is strictly controlled as no GFP was produced prior induction of gene expression by xylose. 16 Another interesting feature was observed: Only 73% of the genetically identical B. megaterium cells showed GFP production while 15% did not ( Fig. 2A, B and D). 16 This culture heterogeneity was described in a different context for B. subtilis before. 18
The Big Picture: Cell Biology with B. megaterium
Within the last years, the in vivo observation of cellular processes ("live cell imaging") in the bacterial cell became more and more common. Much research was commercialized xylose-inducible vector system for B. megaterium: "…one of the most efficient expression systems described in any organism so far" (MoBiTec, Göttingen, Germany).
Express Yourself: Advanced Protein Production using B. megaterium
A novel series of vectors based on the xylose-inducible system was construc ted. 16 All vectors belonging to this "1622" series have an identical multiple cloning site. This feature allows for simple subcloning in various of these vectors. Upstream or downstream of the MCS the coding sequences of small affinity tags, His 6 -or StrepII-tag, where introduced. The production of GFP using all vector constructs was successfully tested with a maximal GFP recovery of up to 17.9 mg/L in shaking flask cultures. 16 The GFP fusion proteins containing an N-or C-terminal His 6 -or StrepII-tag 17 were easily purified by affinity chromatography. Up to 10.8 mg GFP per liter cell possess any obvious alkaline proteases degrading recombinant gene product. Hence, it was sucessfully used for the production of several αand β-amylases important for starch modification reactions in the baking industry and of penicillin amidase essential for the synthesis of novel β-lactam antibiotics. 10 It is also being used industrially for the intracellular production of HIV antigen by the Abbott Laboratories. 11
Sweet Life: Xylose Induced Gene Expression
In 1991, Rygus and Hillen pushed B. megaterium research with the introduction of a strong and xylose-inducible promoter found in the genome of B. megaterium. Under the strict control of the repressor protein XylR, the system was used for the controllable production of intracellular recombinant proteins like β-galactosidase, glucose dehydrogenase, formate dehydrogenase and toxin A. [12] [13] [14] [15] This promoter provided the basis for the effective and removal without cell disruption. Next, a series of secretion vectors based on the xylose-inducible vector system ( Fig. 3) including the sequence of the signal peptide of the lipase A from B. megaterium were constructed using a levansucrase from Lactobacillus reuteri as a model protein. 23 The production and secretion of up to 4 mg levansucrase per liter culture medium was observed. Analogously, 1 mg
Inside Out: Recombinant Protein Production and Secretion into the Growth Medium
In contrast to the intracellular production of recombinant proteins, the secretion of proteins into the surrounding growth medium provides an elegant and easy method to directly purify heterologous proteins from the medium after cell done on the Gram-positive organism B. subtilis especially by Peter Graumann's group and others. [20] [21] [22] For the transfer of these methodologies to the big bug B. megaterium, the intracellular production of recombinant green fluorescent protein (GFP) fusion proteins was a major prerequisite. Due to the size of B. megaterium, a higher resolution of microscopic pictures is expected. Next, we decided to directly optimize the vitamin B 12 -production with the natural producer B. megaterium. [37] [38] [39] Different individual manipulation steps were followed. Beside the genetic manipulation of the existing vector DNA, further direct manipulations of the genetic information of B. megaterium were demanded. 38 The used strategies illustrate the versatility of this bacterium as a biotechnological toolbox. Recombinant overexpression of single genes (cbiX, sirA, fnr and optimized hemA) increased the vitamin B 12 concentration up to 13.5-fold. The integration of the strong xylose-inducible promoter upstream of the hemAXCDBL operon and directed enzyme engineering of HemA to to 28,600 units per liter. By coproduction of SipM and DsrS, encoded on one vector, the extracellular amount of DsrS was increased 3.7-fold. 30
Virus Helps: T7 RNA Polymerase Driven Protein Production in B. megaterium
The B. megaterium gene expression system was completed by the viral T7 RNA polymerase-dependent promoter. This demanded a stable two vector system. However, the origin of replication of all members of the constructed intra-as well as the extracellular vectors was derived from pBC16, 31 which is replicated by the rolling circle mechanism. 32 For the stable presence of two plasmids in one bacterial cell, origins of replication belonging to different compatibility classes are necessary. B. megaterium strain QM B1551 carries seven different plasmids (pBM100-pBM700). 33 One of the corresponding replicons, repBM100, 34 was chosen for a second in parallel replicating plasmid in B. megaterium. 35 While pBC16 derivatives were found to have 50-100 copies per cell, 135 copies of pBM100 are present. 33, 36 of His-tagged and 0.7 mg of Strep-tagged levansucrase were purified directly from the growth medium. 23, 24 The efficiency of the established secretion system was further demonstrated by secretion of 6,098 U/l of a hydrolase from Thermobifida fusca, 25 the recombinant secretion of 40 mg per liter of penicillin amidase from B. megaterium, 26 the export of a keratinase with an activity of 166,200 U/L 27 as well as the production and secretion of 400 µg per liter of recombinant single chain Fv antibody fragments. 28 All vectors of the secretion series are commercialized by the MoBiTec GmbH (Göttingen, Germany). In 2004, Nahrstedt et al. described the detection of the signal peptidase SipM in the genome of B. megaterium necessary for the removal of the signal peptide of secreted proteins. 29 Recombinant protein secretion of (1,3-1,4)-β-glucanase was increased up to 44% when recombinant SipM was co-produced in B. megaterium. Then, one year later, in 2005, these studies were extended on the secretion of a recombinant 200 kDa protein. 19 The dextransucrase DsrS from Leuconostoc mesenteroides secreted into the culture medium of B. megaterium showed an activity of up Especially the production of two proteins mediating antibiotic resistance together with the DNA replication of the plasmids seemed to provide stress to the cells. 43 Due to this increased metabolic burden for the B. megaterium cell, the cells grew slower, did not reach higher optical densities and further, were limited in their protein production process.
Looking into the Magic Gene Forest
During the last years, the sequences of more and more bacterial genomes were made available. This amount of data provides the possibility to have a systematic look into the genes present as well as in the regulatory areas between them. Currently, the genome sequences of two biotechnological important B. megaterium strains are being obtained (unpublished data). For an easy access to the genomic data the MegaBac platform was set up, accessible under megabac.tu-bs.de. * Knowledge of the genetic potential of B. megaterium provides the possibility to complete the whole picture of vitamin B 12 biosynthesis as well as several other biochemical pathways with impact on the productivity of the host cell. Insights into non-coding regions will give details of regulatory mechanisms. bound to its corresponding vitamin B 12 binding domains. 41, 42 
Sometimes More is Less
All directed single manipulations to enhance the cellular vitamin B 12 content were successful. The intracellular vitamin B 12 amount was increased up to almost 40-fold. Next, the individual strategies were combined. The genetic background of B. megaterium strain HBBm1 containing the xylose-inducible promoter upstream of the hemA KK XCDBL operon (40-fold increase) was combined with the recombinant production of the antisense mRNA of hemZ (1.2-fold increase) and with the recombinant overproduction of sirA (4.5-fold increase), respectively. By simple multiplication, a 48-fold and a 180fold increase of B 12 production, respectively, was expected. But the experiments proved these assumptions wrong. The vitamin B 12 content corresponding to the optical density (µg L -1 OD -1 578 nm ) showed a maximal enhancement of only 33-and 37.2-fold, respectively. And the volumetric amount was even worse. Only maximal values increased 13.6-and 19-fold, respectively, were detected. This was the same phenomenon observed for cells carrying two vectors overproducing GFP.
HemA KK by an exchange of two amino acid residues to enhance enzyme stability increased the B 12 content up to almost 40-fold ( Fig. 4) . For this purpose, integration vectors based on the temperature sensitive origin of replication of pE194ts 40 were constructed. 37, 38 The overproduction of the cbiI operon starting from cbiX by chromosomal promoter integration increased the vitamin B 12 content almost 20-fold. The biosynthesis of all tetrapyrroles including vitamin B 12 and heme uses the same precursor molecule, uroporphyrinogen III. After uroporphyrinogen III, the biosynthetic pathways of vitamin B 12 and heme diverge. To repress the flux of this metabolite to the heme biosynthetic path, an antisense RNA strategy to inactivate the hemZ mRNA involved in this competing pathway was established. This was one of the rare examples reported for a successfully employed antisense RNA strategy in bacteria so far. Moreover, overproduction of the recombinant vitamin B 12 binding proteins MetH, GlmS and RtpR, respectively, to prevent vitamin B 12 dependent feedback inhibition, successfully enhanced the vitamin content almost 5-fold. Here, the twin arginine transport (TAT) system, where folded proteins are secreted, could provide an elegant possibility to export the cofactor vitamin B 12 Gene regulating networks can be deduced using the PRODORIC database and the VIRTUAL FOOTPRINT software tool developed in our group (www.prodoric.de). 44 Visualization is achieved via ProdoNet. 45 * The platform is still password protected until the publication of the B. megaterium genome sequence. For accessibility requests contact b.bunk@tu-bs.de.
The Next Revolution: "Systems Biotechnology"
Now, with help of the genome information, the introduction of modern highthroughput technologies as transcriptomics, proteomics and metabolomics to perform a broad "systems biotechnology" approach is possible. However, in our opinion, "systems biotechnology" is more than just measuring high throughput data: These data have to be combined to establish bioinformatic models for the prediction of cellular processes.
The genome data have already been used to deduce metabolic networks and to model metabolic fluxes. The models have been confronted with the results from metabolome and fluxome analyses. 46, 47 Consequently now, DNA microarray and proteomic experiments are the experi mental validation for the proposals. Furthermore, integration of regulatory and metabolic networks is desired. The identification of limiting steps in protein production and the deduction of molecular optimization strategies are the major goals in the future.
